JW (Cayman) Therapeutics (JWCTF) Q3 2024 Earnings

28AugConfirmed
Mar 21
Jun 21
Q1 2024
Q3 2024
-0.13
-0.09
-0.04
0

Details

Expected EPS
-0.0880384
Actual EPS
-0.0797848
Surprise EPS
0.01
Surprise Percent
+9.38%

Description

JW (Cayman) Therapeutics (JWCTF) has reported earnings of -0.0797848 per share for Q3 2024.

0 Comments

Share your thoughts